| [1] |
Berry DA, Inoue L, Shen Y, et al.Modeling the impact of treatment and screening on U.S.breast cancer mortality: a Bayesian approach [J].J Natl Cancer Inst Monogr,2006,36:30-36.
|
| [2] |
Buchholz TA.Radiation therapy for early-stage breast cancer after breast-conserving surgery [J].N Engl J Med,2009,360(1):63-70.
|
| [3] |
Yu X, Prosnitz RR, Zhou S, et al.Symptomatic cardiac events following radiation therapy for left-sided breast cancer:possible association with radiation therapy-induced changes in regional perfusion [J].Clin Breast Cancer, 2003, 4(3):193-197.
|
| [4] |
Clarke M, Collins R, Darby S, et al.Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trials [J].Lancet,2005, 366(9503):2087-2106.
|
| [5] |
Fisher B, Jeong JH, Anderson S, et al.Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation [J].N Engl J Med,2002, 347(8):567-575.
|
| [6] |
Fisher B, Anderson S, Bryant J, et al.Twenty-year follow-up of a randomized trial comparing total mastectomy,lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer [J].N Engl J Med,2002, 347(16):1233-1241.
|
| [7] |
Wapnir I, Anderson S, Mamounas E, et al.Survival after IBTR in NSABP node negative protocols B-13, B-14, B-19, B-20 and B-23 [J].J Clin Oncol,2005,23(16 Suppl):8s-17s.
|
| [8] |
Fisher B, Bryant J, Dignam JJ, et al.Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less [J].J Clin Oncol,2002,20(20):4141-4149.
|
| [9] |
Berry DA, Cronin KA, Plevritis SK, et al.Effect of screening and adjuvant therapy on mortality from breast cancer [J].N Engl J Med,2005, 353(17):1784-1792.
|
| [10] |
Humphrey LL, Helfand M, Chan BK, et al.Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force [J].Ann Intern Med,2002,137(5 Part 1):347-360.
|
| [11] |
Punglia RS, Morrow M, Winer EP, et al.Local therapy and survival in breast cancer [J].N Engl J Med, 2007,356(23):2399-2405.
|
| [12] |
Elkhuizen PH, Hermans J, Leer JW, et al.Isolated late local recurrences with high mitotic count and early local recurrences following breast-conserving therapy are associated with increased risk on distant metastasis [J].Int J Radiat Oncol Biol Phys, 2001,50(2):387-396.
|
| [13] |
Nielsen HM, Overgaard M, Grau C, et al.Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies [J].J Clin Oncol,2006, 24(15):2268-2275.
|
| [14] |
Kyndi M, Overgaard M, Nielsen HM, et al.High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c [J].Radiother Oncol, 2009,90(1):74-79.
|
| [15] |
Nguyen PL, Taghian AG, Katz MS, et al.Breast cancer subtype approximated by estrogen receptor, progesterone receptor,and HER-2 is associated with local and distant recurrence after breast-conserving therapy [J].J Clin Oncol, 2008,26(14):2373-2378.
|
| [16] |
Kyndi M, Sorensen FB, Knudsen H, et al.Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group [J].J Clin Oncol,2008,26(9):1419-1426.
|
| [17] |
Haffty BG, Yang Q, Reiss M, et al.Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer [J].J Clin Oncol, 2006,24(36):5652-5657.
|
| [18] |
Nguyen PL, Taghian AG, Katz MS, et al.Breast cancer subtype approximated by estrogen receptor, progesterone receptor,and HER-2 is associated with local and distant recurrence after breast-conserving therapy [J].J Clin Oncol, 2008,26(14):2373-2378.
|